Ibotenic acid Stats & Data

Ibotenic acid is an excitatory amino acid and a known neurotoxin in laboratory settings; it acts primarily as an agonist at NMDA and certain metabotropic glutamate receptors, and a proportion decarboxylates in vivo or during preparation to muscimol, a potent GABA-A agonist that mediates most desired Amanita effects. Drying and/or heating Amanita material decarboxylates ibotenic acid to muscimol; avoiding raw or under-prepared material meaningfully reduces nausea, dysautonomia, and confusion. Onset can be markedly delayed (often up to 2–3 hours), so redosing during the come-up substantially increases the risk of oversedation, delirium, and emesis later in the session. Clinical series show a characteristic mixture of GI upset (nausea/vomiting), CNS depression (somnolence, confusion), and CNS excitation (agitation, hallucinations); severe cases may require airway protection and benzodiazepines under medical care. Both ibotenic acid and muscimol are rapidly absorbed and readily excreted in urine; laboratory confirmation is possible within hours of ingestion, which also explains historical reports of urine recycling—this does not imply safety and is not a harm-reduction practice. Potency varies widely between Amanita species, locations, and seasons; even adjacent mushrooms can differ substantially, so dosing strategies based on mushroom count or unstandardized extracts are unreliable. Do not drive, swim, or perform hazardous tasks the day of use and consider residual impairment the next day; have a sober sitter to manage sudden somnolence or disorientation. Avoid combining with alcohol, opioids, benzodiazepines, or other sedatives because muscimol-mediated sedation and vomiting increase aspiration and injury risks. Children appear more prone to severe presentations (e.g., ataxia, seizures) after Amanita exposures; pregnant or breastfeeding individuals and those with seizure history should avoid entirely. In the U.S., Amanita muscaria and its constituents are not federally controlled substances, but the FDA has stated that Amanita muscaria and its constituents (including muscimol and ibotenic acid) are not GRAS food additives, and retail products are unregulated; mislabeling and variable decarboxylation are common. Seek urgent care if severe agitation, persistent vomiting, chest pain, seizures, or inability to stay awake occur; clinicians commonly use supportive care with benzodiazepines for agitation or seizures and observation until resolution.